David Kirn

See Remarks, Director, 4D Molecular Therapeutics, Inc.

Bought, 12 months

$0.0M

Sold, 12 months

$5.0M

Companies

Latest trade

Oct 5, 2026

Companies

4D Molecular Therapeutics, Inc.See Remarks, Director −$5.0M

Trades

FDMT Sold 58,333 shares at $12.92 · planned $0.8M Oct 5

FDMT Sold 58,333 shares at $13.90 · planned $0.8M Sep 14

FDMT Sold 69,076 shares at $15.76 · planned $1.1M Aug 19

FDMT Sold 26,842 shares at $10.23 · planned $0.3M Aug 4

FDMT Sold 12,415 shares at $10.05 · planned $0.1M Aug 3

FDMT Sold 15,725 shares at $12.03 · planned $0.2M Jul 10

FDMT Sold 42,608 shares at $12.87 · planned $0.5M Jul 9

FDMT Sold 114,746 shares at $10.47 · planned $1.2M Jun 22

FDMT Sold 1,922 shares at $10.02 · planned $0.0M Jun 1

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.